Adverse event totals15

The totals the trial posted for each group.

1 to 15 of 15

Total	Group	Affected	At risk
Total, all-cause mortality	Part 1
Total, all-cause mortality	Part 2 - Placebo
Total, all-cause mortality	Part 2 - Pregabalin + AZD5213
Total, all-cause mortality	Part 2 - Pregabalin
Total, all-cause mortality	Overall Study
Total, other adverse events	Part 1	19	83
Total, other adverse events	Part 2 - Placebo	8	30
Total, other adverse events	Part 2 - Pregabalin + AZD5213	11	28
Total, other adverse events	Part 2 - Pregabalin	11	30
Total, other adverse events	Overall Study	32	83
Total, serious adverse events	Part 1	0	83
Total, serious adverse events	Part 2 - Placebo	0	30
Total, serious adverse events	Part 2 - Pregabalin + AZD5213	0	28
Total, serious adverse events	Part 2 - Pregabalin	0	30
Total, serious adverse events	Overall Study	0	83

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01928381/event-totals